Partial Response to Repotrectinib in ROS1-Rearranged Lung Squamous Cell Carcinoma: A Brief Report.
0/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.8%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
APA
Yoshida Y, Asahina H, et al. (2026). Partial Response to Repotrectinib in ROS1-Rearranged Lung Squamous Cell Carcinoma: A Brief Report.. Clinical lung cancer, 27(2), 80-84. https://doi.org/10.1016/j.cllc.2026.01.002
MLA
Yoshida Y, et al.. "Partial Response to Repotrectinib in ROS1-Rearranged Lung Squamous Cell Carcinoma: A Brief Report.." Clinical lung cancer, vol. 27, no. 2, 2026, pp. 80-84.
PMID
41621329 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- PD-1 suppresses CAR signaling by forming the inhibitory signalosome colocalizing to CAR microclusters.
- Two Cases of Resected Solitary Pulmonary Capillary Hemangioma with Ground-glass Attenuation on CT Imaging.
- A Case of Sigmoid Colon Cancer with Patent Foramen Ovale and Left-Sided Inferior Vena Cava Initially Detected during the Workup for Cerebral Infarction.
- First Clinical Evidence of Repotrectinib Efficacy in ROS1-Rearranged NSCLC With a D2033N Resistance Mutation: Case Report.
- A case of idiopathic gynecomastia treated by endoscopic reduction mammoplasty.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans.
- Metastatic Pancreatic Adenocarcinoma with Germline BLM and Somatic ATM Mutations: A Case Report and Review of DNA Damage Response.